• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • DeviceTalks Weekly
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » Japan earthquake hurts medical device makers

Japan earthquake hurts medical device makers

March 16, 2011 By MassDevice staff

Japan Medical Device Industry

In Japan, they’re dealing with a death toll sure to rise above 10,000, rolling blackouts and a nuclear disaster of as-yet-undetermined proportions. On Wall Street, investors in medical device makers are contending with issues of their own, as share prices slide and the long-term impact of the Japan earthquake remains unknown.

Japan, the world’s third largest economy, is also a critical player in the global medical device market, ranking just behind the U.S. and European Union markets in terms of market size at just under $25 billion, according to Pacific Bridge Medical, a Bethesda, Md.-based Asian regulatory firm.*

The Dow Jones medical device index has slipped about 3.4 percent to $61.33 since the markets closed the day of the earthquake. Here’s a look at some of the companies with large medical device operations — which were down a collective 3.8 percent as of about noon today — and how they’ve fared since the markets closed Friday, March 11:

Company 3/11 close 3/16 noon EDT % change
Abbott (NYSE:ABT) $48.76 $47.04 -3.5%
Baxter International (NYSE:BAX) $52.60 $50.56 -3.9%
Becton, Dickinson (NYSE:BDX) $78.87 $76.00 -3.6%
Boston Scientific Corp. (NYSE:BSX) $7.51 $7.08 -5.7%
Covidien plc (NYSE:COV) $52.73 $50.42 -4.4%
C.R. Bard (NYSE:BCR) $95.75 $93.83 -2.0%
Edwards Lifesciences (NYSE:EW) $89.27 $86.13 -3.5%
Fresenius Medical Care (NYSE:FMS) $67.39 $65.07 -3.4%
GE Healthcare (NYSE:GE) $20.36 $18.96 -6.9%
Johnson & Johson (NYSE:JNJ) $59.69 $57.76 -3.2%
Medtronic Inc. (NYSE:MDT) $38.08 $36.97 -2.9%
Smith & Nephew (NYSE:SNN) $57.51 $54.12 -3.4%
St. Jude Medical Inc. (NYSE:STJ) $48.78 $47.22 -3.2%
Stryker Corp. (NYSE:SYK) $63.02 $60.73 -3.6%
Volcano Corp. (NYSE:VOLC) $25.96 $23.88 -8.0%
Zimmer Holdings (NYSE:ZMH) $61.68 $60.16 -2.5%

Abbott reported more than $2 billion in sales in Japan during 2010, and has grown its there business by 60 percent in the past three years, according to regulatory filings. Japanese sales account for about 5 percent of total sales for Abbott, Medtronic and Johnson & Johnson. Boston Scientific derives about 13 percent of its total global revenues from its business in Japan and has its Asian Pacific headquarters in Tokyo, according to regulatory filings. In 2010, the company reported just shy of $1 billion in sales for its Japanese unit. St Jude’s Japanese sales amount to 11 percent of its top line, according to Reuters; for Stryker it’s 10 percent and 9 percent for Zimmer Holdings Inc.

Becton Dickinson, which makes 5 percent of its total sales in Japan, has a syringe manufacturing facility in Fukushima, where a nuclear power plant is in danger of melting down. BD shuttered the plant temporarily to asess the damage, which does not appear to be extensive.

The impact of the temblor on the device industry will extend far beyond its immediate impact on The Street. Japan’s infrastructure took a huge hit and large portions of its manufacturing sector, which supplies much of the world’s chips and drives for devices of all stripes, are shut down. The effect on the global supply chain (not to mention the world’s third-largest economy) is likely to be hugely disruptive.

For device makers with large export businesses into Japan, it’s harder to predict the long-term effects, noted Pacific Bridge president Ames Gross.

"Hospitals in that area are going to be flooded with patients, so U.S. sales of medical supplies could increase in that region. On the other side, hospitals that were destroyed will not be buying supplies for the next year," Gross told the news service.

Analysts say any disruption will likely involve consumption, not production.

"We would expect greatest disruptions to the more elective surgical procedures as hospitals in the affected areas focus on critical care in the coming days," Bernstein analyst Derrick Sung told Reuters. "We would expect hip, knee and ICD implants for primary prevention to be more affected."

Most companies with distribution operations on the island are able to supply products from other locations and manufacturing issues have been minor, added William Blair & Co analyst Matthew O’Brien.

*Eds. note: Pacific Bridge Medical is a MassDevice sponsor. Return.

Filed Under: News Well Tagged With: Abbott, Baxter, becton dickinson, Boston Scientific, C.R. Bard, Covidien, Edwards Lifesciences, Exports, Fresenius, GE Healthcare, Johnson and Johnson, Smith & Nephew, stjudemedical, Stryker, Volcano Corp., Zimmer Biomet

In case you missed it

  • Ovid Therapeutics taps Robert Langer to lead scientific advisory board
  • mRNA vaccine led to shingles in a handful of immunocompromised patients
  • Intuitive Surgical beats The Street in Q1
  • Edwards rises after hours on Street-beating Q1
  • Medtronic touts 2-year study results for In.Pact AV drug-coated balloon
  • PhysIQ, Janssen partner on digital therapeutics
  • atHeart Medical launches atrial septal defect occluder trial
  • EU to look into Illumina’s proposed acquisition of Grail
  • LivaNova gains FDA clearance for heart-lung machine
  • FDA just made pooled COVID testing easier
  • FDA clears Zimmer Biomet partial knee system for its Rosa system
  • Benefits of J&J COVID-19 vaccine outweigh risks, EU regulator says
  • Medtronic blood pump recall is serious
  • Tesseract Health raises $80M Series B
  • Johnson & Johnson rises on Street-beating Q1
  • Abbott stock down on mixed bag Q1
  • Once-a-week insulin dosing shows promise in studies

RSS From Medical Design & Outsourcing

  • FDA just made pooled COVID testing easier
    COVID-19 molecular tests that have already been authorized for individual use will have an easier time getting an FDA nod for pooled testing. The FDA said today it will add tests by manufacturers who validated their nasal specimen test for pooling to its list of tests available for use with pooled nasal specimens. This could… […]
  • FDA clears Spinal Elements 3D additive manufactured interbody devices
    Spinal Elements today said it received FDA 510(k) clearance for its Lucent 3D line of 3D-printed interbody devices. The Lucent 3D implant has a strut-and-lattice structure with a bone graft chamber access lid that is designed for a surgeon to deliver large amounts of tightly packed graft inside the interbody structure. The lid design helps… […]
  • Medtronic blood pump recall is serious
    Medtronic is recalling a blood pump that can stop during cardiopulmonary bypass surgery due to electrical failure. The Bio-Console 560 extracorporeal blood pumping console is used to pump and return blood to a person during bypass, a procedure that temporarily takes over the function of the heart and lungs. The cardiopulmonary bypass procedure provides both… […]
  • In situ cure technology molds next-gen medical implants
    Innovation in silicone technology has moved beyond defining specific material characteristics and into offering implantable devices that cure and form into shape inside the human body. Benny David, NuSil from Avantor Medical device manufacturers have long relied on highly purified silicone elastomers to fabricate components or entire devices for implantation. Now, recent innovations offer manufacturers… […]
  • How to prevent and troubleshoot short shots in medtech molding
    Deliberate processes to identify and remediate the problem can yield high-quality products and keep patients safe. Shane Vandekerkhof, RJG Short shots are among the most common and visually obvious quality issues most molders face, but they can cause fatal flaws in medical devices. Imagine if a luer lock connector was short. You run the risk… […]
  • AdvaMed launches medtech podcast
    AdvaMed today announced the launch of a new podcast, MedTech POV. AdvaMed president and CEO Scott Whitaker hosts the podcast, which covers the intersection of medtech and policy from a variety of perspectives. Each episode will feature discussions with medtech and healthcare policy leaders on issues that are driving the day — from business to… […]
  • This wearable could signal cytokine storms
    Researchers at the University of Texas at Dallas have developed a sweat sensor that could detect cytokine storms in patients suspected of having COVID-19 and other illnesses. Early on in the pandemic, doctors found that patients who developed a surge of pro-inflammatory immune proteins, called “cytokine storms,” were more often the sickest and at the… […]
  • How to evaluate laser performance for medical device manufacturing
    Laser processing provides automation and efficiencies that help meet FDA regulations and produce superior medical device components. David Locke, ACSYS Lasertechnik US Laser systems have become essential to the production of better-designed medical devices. The precision, repeatability and scale needed to manufacture next-generation medical products rely heavily on the advantages that lasers bring to contract… […]
  • EPA delayed notifying residents of ethylene oxide emissions
    The EPA delayed notifying neighbors of an Illinois medical device sterilization plant of ethylene oxide (EtO) emissions the agency measured in 2018, according to an inspector general’s report released yesterday. The report also says that “leadership” in the agency’s Office of Air and Radiation also failed to conduct public meetings with residents either near the… […]
  • 9 medical devices you should keep an eye out for in 2021
    The medical device industry weathered the COVID-19 pandemic well — and is now set to roll out a host of innovations in 2021. Economists generally expect the U.S. to see a boom as we emerge from the pandemic and resulting recession. Medtech companies appear set to ride the wave this year, with plans to seek… […]
  • Greenlight Guru to provide QMS to NIH diagnostics program
    NIH has chosen Greenlight Guru to provide quality management software for its COVID-19 rapid diagnostics program. The agency launched the Rapid Acceleration of Diagnostics (RADx) program in March 2020 to speed the development, commercialization and implementation COVID-19 testing technologies. As the only QMS provider currently available to all projects in the RADx program, Greenlight Guru… […]

Leave a Reply Cancel reply

You must be logged in to post a comment.

Primary Sidebar

DeviceTalks by MassDevice · How Zimmer Biomet is competing in ortho’s data race; Do medical devices carry physics-based biases?

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS